BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8402030)

  • 21. Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors.
    Hudolin T; Kastelan Z; Knezevic N; Goluza E; Tomas D; Coric M
    Int J Surg Pathol; 2012 Feb; 20(1):15-8. PubMed ID: 22180527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of lymphangiography in staging testicular seminoma.
    Marks LB; Shipley WU; Walker TG; Waltman AC
    Urology; 1991 Sep; 38(3):264-6. PubMed ID: 1887542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphangiography combined with biopsy and computer tomography to detect lymph node metastases in localized prostate cancer.
    Rørvik J; Halvorsen OJ; Albrektsen G; Haukaas S
    Scand J Urol Nephrol; 1998 Apr; 32(2):116-9. PubMed ID: 9606783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I.
    Weissbach L; Boedefeld EA
    J Urol; 1987 Jul; 138(1):77-82. PubMed ID: 3599225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
    Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
    Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sonography and CT in staging nonseminomatous testicular tumors.
    Poskitt KJ; Cooperberg PL; Sullivan LD
    AJR Am J Roentgenol; 1985 May; 144(5):939-44. PubMed ID: 2580425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
    Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
    J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor.
    Lien HH; Stenwig AE; Ous S; Fosså SD
    Acta Radiol Diagn (Stockh); 1986; 27(2):199-203. PubMed ID: 3716866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of computed tomography in the staging of testicular tumors.
    Strohmeyer T; Geiser M; Ackermann R; Mumperow E; Hartmann M
    Urol Int; 1988; 43(4):198-200. PubMed ID: 3055609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial.
    Laukka M; Mannisto S; Beule A; Kouri M; Blomqvist C
    Acta Oncol; 2020 Jun; 59(6):660-665. PubMed ID: 32048533
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphography in the diagnosis of non-seminoma tumours of the testis.
    Wobbes T; Blom JM; Oldhoff J; Schraffordt Koops H
    J Surg Oncol; 1982 Jan; 19(1):1-4. PubMed ID: 7057637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer.
    Williams SB; Kacker R; Winston D; Bahnson E; Steele GS; Richie JP
    J Urol; 2011 Dec; 186(6):2245-8. PubMed ID: 22014805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of CT and lymphography: distinguishing retroperitoneal metastases from nonseminomatous testicular tumors.
    Dunnick NR; Javadpour N
    AJR Am J Roentgenol; 1981 Jun; 136(6):1093-9. PubMed ID: 6786019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer.
    Sioris T; Järvenpää R; Kuukasjärvi P; Helin H; Saarelainen S; Tarkka M
    Eur J Cardiothorac Surg; 2003 Mar; 23(3):403-8. PubMed ID: 12614814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels.
    Höltl L; Peschel R; Knapp R; Janetschek G; Steiner H; Hittmair A; Rogatsch H; Bartsch G; Hobisch A
    Urology; 2002 Jan; 59(1):114-8. PubMed ID: 11796292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Position of surveillance therapy in clinical stage I testicular non-seminoma].
    Thon WF; Sparwasser C; Gilbert P; Altwein JE
    Urol Int; 1987; 42(6):445-9. PubMed ID: 2834854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.